D'Anglemont De TassignyA, IDéEJM, CorotAC: Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer). Invest Radiol, 2001; 36:276–282.
2.
HerbertAS, DavidsonC, KuehneAI, et al.: Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. mBio, 2015; 6:e00565–15.
3.
AsifM: A review on role of the calcium sensitive inotropic agent, levosimendan and its metabolites. Mini Rev Med Chem, 2016. [Epub ahead of print]; DOI: 10.2174/1389557516666160905094721.
4.
de WinterJM, JoureauB, SequeiraV, et al.: Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene. Skelet Muscle, 2015; 5:12.
5.
OnodyP, AranyiP, TurocziZ, et al.: Levosimendan administration in limb ischemia: Multicomponent signaling serving kidney protection. PLoS One, 2016; 11:e0163675.
6.
DoorduinJ, SinderbyCA, BeckJ, et al.: The calcium sensitizer levosimendan improves human diaphragm function. Am J Respir Crit Care Med, 2012; 185:90–95.
7.
RingelsteinEB, ThijsV, NorrvingB, et al.: Granulocyte colony-stimulating factor in patients with acute ischemic stroke: Results of the AX200 for Ischemic Stroke trial. Stroke, 2013; 44:2681–2687.
8.
MizumaA, YamashitaT, KonoS, et al.: Phase II trial of intravenous low-dose granulocyte colony-stimulating factor in acute ischemic stroke. J Stroke Cerebrovasc Dis, 2016; 25:1451–1457.
9.
BelanE: LINEs of evidence: Noncanonical DNA replication as an epigenetic determinant. Biol Direct, 2013; 8:22.
10.
SciamannaI, GualtieriA, PiazzaPF, SpadaforaC: Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression. Oncotarget, 2014; 5:8039–8051.
11.
BareggiSR, CornelliU: Clioquinol: Review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther, 2012; 18:41–46.
12.
Gumienna-KonteckaE, Pyrkosz-BulskaM, SzebesczykA, OstrowskaM: Iron chelating strategies in systemic metal overload, neurodegeneration and cancer. Curr Med Chem, 2014; 21:3741–3767.
13.
YasudaH, YoshidaK, YasudaY, TsutsuiT: Infantile zinc deficiency: Association with autism spectrum disorders. Sci Rep, 2011; 1:129.
14.
LeeEJ, LeeH, HuangTN, et al.: Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation. Nat Commun, 2015; 6:7168.
15.
TurnerRT, EvansGL, SlukaJP, et al.: Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene. Endocrinology, 1998; 139:3712–3720.
16.
PariniP, AngelinB, RudlingM: Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler Thromb Vasc Biol, 1997; 17:1800–1805.
NelsonEA, BarnesAB, WiehleRD, et al.: Clomiphene and its isomers block ebola virus particle entry and infection with similar potency: Potential therapeutic implications. Viruses, 2016; 8. pii:E206.
19.
CholeraM, Chainani-WuN: Management of pemphigus vulgaris. Adv Ther, 2016; 33:910–958.
20.
RankinAL, SethN, KeeganS, et al.: Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis. J Immunol, 2013; 191:4540–4550.
